EUVIMEDEUVIMED entdecken
Open Access

A dual fluorescent herpes simplex virus type 1 recombinant reveals divergent outcomes of neuronal infection

Luke F Domanico iD, Gary P Dunn, Oren Kobiler iD, Matthew P Taylor iD

Journal of Virology · 2024

DOI: 10.1128/jvi.00032-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Luke F Domanico und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Cell Biology, Montana State University, Bozeman, Montana, USA. Hauptthemen laut MEDLINE: Herpes Simplex, Herpesvirus 1, Human, Neurons. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Israel Science Foundation (ISF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Critical stages of lytic herpes simplex virus type 1 (HSV-1) replication are marked by the sequential expression of immediate early (IE) to early (E), then late (L) viral genes. HSV-1 can also persist in neuronal cells via a non-replicative, transcriptionally repressed infection called latency. The regulation of lytic and latent transcriptional profiles is critical to HSV-1 pathogenesis and persistence. We sought a fluorescence-based approach to observe the outcome of neuronal HSV-1 infection at the single-cell level. To achieve this goal, we constructed and characterized a novel HSV-1 recombinant that enables discrimination between lytic and latent infection. The dual reporter HSV-1 encodes a human cytomegalovirus-immediate early (hCMV-IE) promoter-driven enhanced yellow fluorescent protein (eYFP) to visualize the establishment of infection and an endogenous mCherry-VP26 fusion to report lytic replication. We confirmed that viral gene expression, replication, and spread of infection are not altered by the incorporation of the fluorescent reporters, and fluorescent protein (FP) detection virtuously reports the progression of lytic replication. We demonstrate that the outcome of HSV-1 infection of compartmentalized primary neurons is determined by viral inoculating dose: high-dose axonal inoculation proceeds to lytic replication, whereas low-dose axonal inoculation establishes a latent HSV-1 infection. Interfering with low-dose axonal inoculation via small molecule drugs reports divergent phenotypes of eYFP and mCherry reporter detection, correlating with altered states of viral gene expression. We report that the transcriptional state of neuronal HSV-1 infection is variable in response to changes in the intracellular neuronal environment. IMPORTANCE Herpes simplex virus type 1 (HSV-1) is a prevalent human pathogen that infects approximately 67% of the global human population. HSV-1 invades the peripheral nervous system, where latent HSV-1 infection persists within the host for life. Immunological evasion, viral persistence, and herpetic pathologies are determined by the regulation of HSV-1 gene expression. Studying HSV-1 gene expression during neuronal infection is challenging but essential for the development of antiviral therapeutics and interventions. We used a recombinant HSV-1 to evaluate viral gene expression during infection of primary neurons. Manipulation of cell signaling pathways impacts the establishment and transcriptional state of HSV-1 latency in neurons. The work here provides critical insight into the cellular and viral factors contributing to the establishment of latent HSV-1 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes SimplexHerpesvirus 1, HumanNeuronsAnimalsHumansChlorocebus aethiopsCytomegalovirusGene Expression Regulation, ViralGenes, ReporterLuminescent ProteinsVero CellsVirus LatencyVirus Replication

Stichwörter der Autor:innen

HSV-1fluorescent proteinlatencyneurontranscriptionviral replication

Substanzen

Luminescent Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Cell Biology, Montana State University, Bozeman, Montana, USA.
  • Department of Clinical Microbiology and Immunology, School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

ORCID-Profile: Luke F Domanico, Oren Kobiler, Matthew P Taylor

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • Israel Science Foundation (ISF)
  • Montana Agricultural Experiment Station (MAES)

Zitieren

APA

Domanico, L. F., Dunn, G. P., Kobiler, O., & Taylor, M. P. (2024). A dual fluorescent herpes simplex virus type 1 recombinant reveals divergent outcomes of neuronal infection. Journal of Virology. https://doi.org/10.1128/jvi.00032-24

Vancouver

Domanico LF, Dunn GP, Kobiler O, Taylor MP. A dual fluorescent herpes simplex virus type 1 recombinant reveals divergent outcomes of neuronal infection. Journal of Virology. 2024. doi:10.1128/jvi.00032-24

BibTeX
@article{Domanico2024,
  author = {Domanico, Luke F and Dunn, Gary P and Kobiler, Oren and Taylor, Matthew P},
  title = {A dual fluorescent herpes simplex virus type 1 recombinant reveals divergent outcomes of neuronal infection},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.00032-24}
}
Kostenlos starten →